Psychedelic drug DMT to be trialled in UK to treat depression

Exclusive: UK regulators give go-ahead for drug to be trialled ahead of possible treatment alongside psychotherapy

UK regulators have given the go-ahead for the first clinical trial of the use of the psychedelic drug dimethyltriptamine (DMT) to treat depression.

The trial will initially give the drug - known as the spirit molecule" for the powerful hallucinogenic trips it induces - to healthy individuals, but it is expected to be followed by a second trial in patients with depression, where DMT will be given alongside psychotherapy.